Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Intarcia Therapeutics, Inc. patents

Patents where

Current Assignee

Name

Intarcia Therapeutics, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9889085 Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c	Patent 9889085 was granted and assigned to Intarcia Therapeutics, Inc. on February, 2018 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	9889085	February 13, 2018
‌ US Patent 9572889 Devices, formulations, and methods for delivery of multiple beneficial agents	Patent 9572889 was granted and assigned to Intarcia Therapeutics, Inc. on February, 2017 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	9572889	February 21, 2017
‌ US Patent 9526763 Solvent/polymer solutions as suspension vehicles	Patent 9526763 was granted and assigned to Intarcia Therapeutics, Inc. on December, 2016 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	9526763	December 27, 2016
‌ US Patent 9095553 Solvent/polymer solutions as suspension vehicles	Patent 9095553 was granted and assigned to Intarcia Therapeutics, Inc. on August, 2015 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	9095553	August 4, 2015
‌ US Patent 8926595 Devices, formulations, and methods for delivery of multiple beneficial agents	Patent 8926595 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2015 by the United States Patent and Trademark Office.		Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	8926595	January 6, 2015
‌ US Patent 8940316 Osmotic delivery comprising an insulinotropic peptide and uses thereof	Patent 8940316 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2015 by the United States Patent and Trademark Office.		Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	8940316	January 27, 2015
‌ US Patent 11214607 Glucagon-receptor selective polypeptides and methods of use thereof	Patent 11214607 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2022 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	11214607	January 4, 2022
‌ US Patent 10501517 Glucagon-receptor selective polypeptides and methods of use thereof	Patent 10501517 was granted and assigned to Intarcia Therapeutics, Inc. on December, 2019 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10501517	December 10, 2019
‌ US Patent 9539200 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 9539200 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2017 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	9539200	January 10, 2017
‌ US Patent 8992961 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles	Patent 8992961 was granted and assigned to Intarcia Therapeutics, Inc. on March, 2015 by the United States Patent and Trademark Office.		Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	8992961	March 31, 2015
‌ US Patent 8992962 Two-piece, internal-channel osmotic delivery system flow modulator	Patent 8992962 was granted and assigned to Intarcia Therapeutics, Inc. on March, 2015 by the United States Patent and Trademark Office.	Intarcia Therapeutics	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	8992962	March 31, 2015
‌ US Patent 10925639 Implant placement and removal systems	Patent 10925639 was granted and assigned to Intarcia Therapeutics, Inc. on February, 2021 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10925639	February 23, 2021
‌ US Patent D962433 Implant placement guide	Patent D962433 was granted and assigned to Intarcia Therapeutics, Inc. on August, 2022 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D962433	August 30, 2022
‌ US Patent 10527170 Osmotic delivery systems and piston assemblies for use therein	Patent 10527170 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2020 by the United States Patent and Trademark Office.	Intarcia Therapeutics	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10527170	January 7, 2020
‌ US Patent 10363287 Method of manufacturing an osmotic delivery device	Patent 10363287 was granted and assigned to Intarcia Therapeutics, Inc. on July, 2019 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10363287	July 30, 2019
‌ US Patent 11246913 Suspension formulation comprising an insulinotropic peptide	Patent 11246913 was granted and assigned to Intarcia Therapeutics, Inc. on February, 2022 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	11246913	February 15, 2022
‌ US Patent D912249 Implant removal tool	Patent D912249 was granted and assigned to Intarcia Therapeutics, Inc. on March, 2021 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D912249	March 2, 2021
‌ US Patent D860451 Implant removal tool	Patent D860451 was granted and assigned to Intarcia Therapeutics, Inc. on September, 2019 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D860451	September 17, 2019
‌ US Patent 10231923 Rapid establishment and/or termination of substantial steady-state drug delivery	Patent 10231923 was granted and assigned to Intarcia Therapeutics, Inc. on March, 2019 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10231923	March 19, 2019
‌ US Patent 10869830 Rapid establishment and/or termination of substantial steady-state drug delivery		Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10869830	December 22, 2020
‌ US Patent D933219 Implant removal tool and assembly	Patent D933219 was granted and assigned to Intarcia Therapeutics, Inc. on October, 2021 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D933219	October 12, 2021
‌ US Patent 10835580 Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug	Patent 10835580 was granted and assigned to Intarcia Therapeutics, Inc. on November, 2020 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10835580	November 17, 2020
‌ US Patent D835783 Implant placement guide	Patent D835783 was granted and assigned to Intarcia Therapeutics, Inc. on December, 2018 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D835783	December 11, 2018
‌ US Patent 10159714 Compositions, devices and methods of use thereof for the treatment of cancers	Patent 10159714 was granted and assigned to Intarcia Therapeutics, Inc. on December, 2018 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	10159714	December 25, 2018
‌ US Patent D840030 Implant placement guide	Patent D840030 was granted and assigned to Intarcia Therapeutics, Inc. on February, 2019 by the United States Patent and Trademark Office.	Intarcia Therapeutics, Inc.	Intarcia Therapeutics, Inc.	United States Patent and Trademark Office	D840030	February 5, 2019

Results per page:

29 results

0 selected

29 results

0 selected